clinical trial diversity

The Trials Were Always There — Patients Just Couldn’t Find Them

This structural problem calls for a structural solution, requiring no new science, regulation, or data. 

When Evidence Gap Becomes a Commercial Liability

The MENA evidence gap for selected portfolios is becoming a commercial liability for drugmakers that could have been prevented at the design stage.

AI Won’t Replace Clinical Trial Teams, But It Fixes the Bottlenecks That Keep Patients Out

We don’t have a shortage of willing patients — instead we have a shortage of scalable ways to identify and engage them responsibly. AI, used meaningfully offers a reliable path forward.

Rethinking Where Patient Recruitment Begins

The patients are there. Our recruitment models just aren’t reaching them. Digital patient recruitment is proving to be not just an alternative, but an even more effective approach.

Patient Recruitment Reimagined: How AI is Key to Clinical Trial Acceleration

In an environment where speed, equity, and scientific rigor are all imperative, modernizing patient recruitment is no longer a future goal. It is a present necessity.

Patient-Centricity is Reliant on Representative Clinical Studies

Recent FDA guidance aims to improve research inclusivity and the generalizability of clinical findings by ensuring diverse participant representation — it’s about better science, improved patient outcomes, and equitable healthcare access.

Better Science, Better Medicine: How Clinical Research Advances Women’s Health

Modern trial designs, digital solutions and a deeper understanding of patient realities are helping to open research to more people, including women and others who have historically been underrepresented.

Navigating 2025: Three Key Trends Shaping the Future of Pharma

Here are three key trends that pharma leaders and clinical operations teams should monitor this year, along with a checklist of strategic priorities to stay ahead.

Streamlined Participant Payments Unlock Clinical Trial Access for All

Participant payment options should include a variety of stipend and micropayment methods to meet participant preferences. Increasing the diversity of payment methods with both banked and unbanked options enhances flexibility, catering to a diverse and international participant base with varying payout needs.

Implementing Inclusivity: Putting Clinical Trial Equity Into Practice

In the realm of inclusivity and equity, planning early and engaging key stakeholders throughout the process makes it possible to make these changes while also safeguarding participants. How can researchers put clinical trial equity into practice?

The Role of Medical Affairs in Bridging Clinical Trial Access for All Patients

Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions.

To Continue the Momentum in Women’s Health, We Have No Time to Lose

We must look both “upstream” – at advocating for change on an institutional level – and “downstream” – at what we can do as individuals to help women secure the care they need.

Search, Click, Enroll? What Clinical Trials Can Learn from E-commerce

Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases.

Five Strategies To Boost Clinical Trial Diversity

Without taking specific steps to improve trial diversity, advances in inclusive treatments will continue at a snail’s pace.

Alleviating Patient Burden in Clinical Trials: Modeling a Consumer-Grade Experience

By leveraging analytics to optimize the patient experience in clinical trials, patient attrition will decrease, improving clinical outcomes and research goals.